In line with these considerations, recent studies have indeed indicated an association between circulating adiponectin levels and anxiety-like behavior and depression, both in humans and rodents (Nicolas et al., 2015), an effect potentially mediated by hippocampal mechanisms involving changes in Bdnf expression (Yau et al., 2014). This evidence concerns the gene ADIPOQ and depressive symptom measurement.